In this issue:
Biological immunotherapy for psoriasis and time to incident inflammatory arthritis
Rituximab for polymyalgia rheumatica
Bimekizumab in axial spondyloarthritis
TNF inhibitors and methotrexate monotherapy in JIA
Prednisone and tocilizumab effects on haemoglobin A1C in GCA
Perioperative TNF inhibition and survival of THA
Tapering/discontinuation of bDMARDs and tsDMARDs in RA
Withdrawal of methotrexate in RA patients on bDMARDs/tsDMARDs
ICI-induced arthralgia and OS in cancer patients
Long-term tocilizumab treatment in GCA
Interstitial lung disease in RA patients treated with DMARDs
Please login below to download this issue (PDF)